Veterinary CRO and CDMO Market was valued at USD 6.23 billion in 2023 and is expected to reach USD 13.3. billion by 2032, growing at a CAGR of 8.84% over the forecast period of 2024-2032.
The Veterinary CRO & CDMO Market Report. It explores regional differences and emerging health challenges, including that of animal disease incidence and prevalence rates. This report investigates veterinary drug development and clinical trials and the success rates and major therapeutic areas. It explores the nationwide trends in prescribing pharmaceuticals, biologics, and feed additives by region. The report also offers volumes of production and usage of veterinary drugs, indicating the penetration of the market and demand in the future. It includes a comprehensive breakdown of veterinary healthcare expenditures by government, insurance, and out-of-pocket expenditure. It examines regulatory approvals and compliance trends, identifying evolving requirements across leading markets. Increasing investments in animal healthcare are driving the Veterinary CRO and CDMO market, indicating that animal health is gaining importance. The United States is witnessing a steady increase in pet care expenditure, with spending amounting to USD 136.8 billion in 2022 alone, as per the American Pet Products Association (APPA), further augmenting the need for veterinary services.
Drivers
The growing global pet population and intensified livestock production are increasing the demand for veterinary medicines and vaccines, thereby driving the market for CRO and CDMO services.
The global market for Veterinary CRO & CDMO is majorly driven by the growing pet population worldwide and the rising livestock production. As of 2024, the total pet population globally is over 1 billion pets, with cats being the most owned pet. In particular, 52% of men own cats, while 48% of cat owners are women, and 47% of pet owners are first-time pet owners. Concurrently, livestock production has expanded significantly. For example, India's milk production under the 2023-24 period reached 239.30 million tonnes, making India the largest producer in the world and representing a 3.78% increase over the previous year. The growing adoption of pets and livestock production requires veterinary medicines and vaccines, which leads to the high demand for dedicated services provided by Veterinary CROs and CDMOs. These organizations are crucial in assisting pharmaceutical companies by delivering vet-tailored research, development, and manufacturing services. Growth in the pet population drives demand for new pet health solutions, while increasing livestock production makes vaccines and treatments even more critical to maintaining animal health and productivity. As a result, the Veterinary CRO and CDMO market is growing in response to the rising demand of these services by the companion animal and livestock owner. This trend underscores the critical role of these organizations in advancing veterinary healthcare and supporting the global food supply chain.
Restraints:
High research and development costs, along with stringent regulatory challenges, act as significant restraints, particularly for smaller companies, limiting their ability to engage CRO and CDMO services.
The veterinary CRO and CDMO market faces challenges in the high R&D costs and stringent regulatory requirements from the government. Phase III clinical trials, which are critical for evaluating the effectiveness and safety of new veterinary drugs, are a particularly expensive undertaking, with single trials costing more than $100 million. These can be such jumping costs that smaller companies are discouraged from spending on creating new products, thus limiting progress in the industry.
Besides financial issues, the industry is required to operate in complex and shifting regulatory environments. An example is the European Medicines Agency (EMA), which operates under Regulation (EU) 2019/6 with very strict guidelines to follow regarding veterinary medicinal products. Tackling those varied sets of requirements increases approval times and costs, making it even more difficult for smaller companies to commercialize new products. In addition, the industry is being scrutinized for antimicrobial resistance (AMR). Non-therapeutic uses of antibiotics in animal agriculture, which are often coupled with prophylactic uses of veterinary antibiotics, are significant drivers of AMR, and regulators across the globe have responded by putting more severe controls in place, limiting the uses of antibiotics in animals. The need to have effective treatments available, alongside the necessity of minimizing AMR, has resulted in more stringent guidelines and increased surveillance.
Opportunities:
The rising interest in personalized veterinary medicine offers CROs and CDMOs the chance to develop tailored treatments based on individual animal genetics and characteristics.
This growth in personalized veterinary medicine opens tremendous opportunities for CROs and CDMOs. It personalizes medicine for each animal based on genetic and health information, allowing more precise, powerful treatments. In 2023, US spending on pets was $147 billion, and $38.3 billion of that was for veterinary care, so we know Americans value their pets and their pets' health. This increasing expenditure highlights the need for premium and personalized medicine to fit the veterinary needs of the patients.
The rising costs of pet care, propelled by forces like private equity firms merging veterinary practices, caused prices of veterinary services to jump 6.2% from July 2023 to July 2024. Such trends highlight the growing demand for more effective and tailored treatment alternatives, and through personalized medicine, CROs and CDMOs can support in providing those solutions. Additionally, the fact that 91% of pet owners report feeling financially stressed because of escalating care costs suggests an opportunity for solutions that not only improve outcomes but also reduce lifetime costs. By concentrating on tailored treatments, CROs and CDMOs can mitigate these challenges, developing protocols that deliver both increased effectiveness and cost-effectiveness over time.
Challenges:
Ethical concerns regarding animal testing and welfare present challenges, as balancing necessary research with ethical treatment raises debates and potential restrictions on certain testing practices.
Increasing levels of ethical scrutiny of existing animal use in veterinary research are driven by new data on the level of animal use, together with public sentiment. In a 2024 survey, 85% of Americans said animal experiments should be replaced with modern research. According to some recent estimates, about 200 million animals are used in medical research every year worldwide, indicating that large-scale animal testing exists. In the U.S., 2023 saw a 9% increase in procedures that cause unmitigated pain or distress to animals; 62,241 subjects were affected. Such statistics have sharpened ethical debates, resulting in calls for more stringent regulations and the use of alternative testing methods in veterinary research.
By Animal Type
In 2023, the livestock animal segment accounted for the largest revenue share of 63% of the market. This dominance is ascribed to the rising requirement for veterinary pharmaceuticals and vaccines in large-scale farming systems. The livestock sector is one major contributor to agricultural GDP in various countries, as per government statistics. For example, the U.S. Department of Agriculture released figures showing that livestock, dairy, and poultry production made up a large share of U.S. agricultural production. Optimized veterinary products are required for livestock due to the high production pressure and high health standards for the animals, and livestock remains the primary target for CRO and CDMO service providers.
Government initiatives to improve food safety and animal welfare are also driving growth in livestock health solutions. Similarly, in the EU, a strategy for Animal Health is focusing on the prevention and control of diseases in livestock to enhance agricultural productivity, which is also anticipated to play an important role in the growth of veterinary CRO and CDMO market in the region.
By Service Type
The development segment accounted for the largest revenue share of over 31% in 2023. This is because veterinary therapeutics are becoming more complex, and novel drug development is needed. One trend supporting this scenario is government initiatives that support research and development in animal health, such as grants from the National Institutes of Health (NIH) that fund veterinary research. Others in the development sector benefit from government programs that foster cooperation between academia and industry to encourage innovation in veterinary medicine. Since the development component of the market is vital, these partnerships streamline and improve drug development processes. Demand for development services is also an important aspect of the veterinary drugs market, as most new veterinary drugs must meet tight regulatory guidelines around safety and efficacy. The U. S. Food and Drug Administration (FDA) and other governmental authorities set regulations that aid in the growth of the development segment.
By Application
In 2023, the medicine segment accounted for the largest share of the market. The market is dominated by the growing number of animal diseases, including zoonotic infections and cancer, that require the advancement of veterinary pharmaceuticals. Government reports emphasized the need for these health challenges to be tackled. For example, the Centers for Disease Control and Prevention (CDC) highlight the importance of effective treatments for zoonotic diseases, which are diseases that can be transmitted between animals and humans. Potential collaboration opportunities also exist through government initiatives to improve public health through improved animal health management and the demand for safe and effective veterinary medicines.
This segment in medicine also benefits from advancements in veterinary diagnostics, treatment technologies that enable animal owners to make decisions based on their pets' health, and is often supported by government funding for research and development. This support helps fuel innovative treatments in the veterinary medicine sector, which is what makes up the dominant segment.
In 2023, North America held the largest share of the market in the presence of robust animal health infrastructure and investment in veterinary services. The U.S. is a powerhouse for veterinary innovation and a point of significant government support for animal health initiatives. For example, the United States Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS), whose veterinary services are key programs that promote animal health and help the region maintain its leadership in the marketplace. The European market is spearheaded by well-developed animal welfare practices and strict regulation of compliance, driving the same interest for quality veterinary pharmaceuticals. Market drivers in this region include increasing pet ownership and rising awareness about animal health, which generate demand for new drugs, a collaboration between the European pharmaceutical industry and CRO/CDMO service providers, and technology innovation.
During the forecast period, the Asia Pacific region is expected to be the fastest growing region owing to rapidly growing demand for veterinary services and products in emerging countries such as China and India. The rapid development is also fostered by the use of government exercises in these countries to improve animal health infrastructure and encourage veterinary research. by offerings like advanced veterinary technologies, as illustrated by China's focus on better livestock health, India, whose initiatives to enhance animal health research have been a major growth factor for the market within the region. Collaborations between local firms and international players further spur growth in the Asia Pacific by enabling the adoption of advanced technologies and innovative solutions in veterinary healthcare.
Key Service Providers/Manufacturers
Charles River Laboratories
Vetio
LABIANA Group
TriRx Pharmaceutical Services
Aenova Group
Oncovet Clinical Research (OCR)
Argenta Group (KLIFOVET GmbH)
Clinvet
VETSPIN
Knoell
IDEXX Laboratories Inc.
CZ Vaccines
Kela Health
Argenta Limited
AB7 Group
Labcorp Drug Development
Zoetis Inc.
Inotiv Inc.
Jubilant Biosys
Syneos Health Inc.
In the April 2023 issue, the American Pet Products Association reported on the increasing ownership of cats and dogs by millennials and Gen Z, along with the enhanced desire to acquire sophisticated veterinary products and services.
The U.S. Department of Agriculture reported on initiatives in January 2023 to improve animal health and increase disease surveillance and control measures, encouraging the further expansion of the veterinary CRO and CDMO market.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 6.23 Billion |
| Market Size by 2032 | USD 13.3 Billion |
| CAGR | CAGR of 8.84% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Animal Type (Livestock Animals, Companion Animals) • By Service Type (Discovery, Manufacturing, Development, Packaging & Labeling, Market Approval & Post-marketing {Early Phase/Preclinical, Late Phase/Clinical}) • By Application (Medicines, Medical Devices {Pharmaceuticals, Biologics, Others}) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Charles River Laboratories, Vetio, LABIANA Group, TriRx Pharmaceutical Services, Aenova Group, Oncovet Clinical Research (OCR), Argenta Group (KLIFOVET GmbH), Clinvet, VETSPIN, Knoell, IDEXX Laboratories Inc., CZ Vaccines, Kela Health, Argenta Limited, AB7 Group, Labcorp Drug Development, Zoetis Inc., Inotiv Inc., Jubilant Biosys, Syneos Health Inc. |
Ans. The projected market size for the Veterinary CRO and CDMO Market is USD 13.33 billion by 2032.
Ans. The CAGR of the Veterinary CRO and CDMO Market is 8.84% during the forecast period of 2024-2032.
Ans: The North American region dominated the Veterinary CRO and CDMO Market in 2023.
Ans: High research and development costs, along with stringent regulatory challenges, act as significant restraints, particularly for smaller companies, limiting their ability to engage CRO and CDMO services.
Ans: The Livestock Animals segment dominated the Veterinary CRO and CDMO Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence & Prevalence of Animal Diseases (2023)
5.2 Veterinary Drug Development & Trials (2023)
5.3 Veterinary Prescription Trends by Region (2023)
5.4 Production & Usage Volumes of Veterinary Pharmaceuticals (2020-2032)
5.5 Regulatory Approvals & Compliance Trends (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Veterinary CRO and CDMO Market Segmentation, By Animal Type
7.1 Chapter Overview
7.2 Livestock Animals
7.2.1 Livestock Animals Market Trends Analysis (2020-2032)
7.2.2 Livestock Animals Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Companion Animals
7.3.1 Companion Animals Market Trends Analysis (2020-2032)
7.3.2 Companion Animals Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Veterinary CRO and CDMO Market Segmentation, By Service Type
8.1 Chapter Overview
8.2 Discovery
8.2.1 Discovery Market Trends Analysis (2020-2032)
8.2.2 Discovery Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Manufacturing
8.3.1 Manufacturing Market Trends Analysis (2020-2032)
8.3.2 Manufacturing Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Development
8.4.1 Development Market Trends Analysis (2020-2032)
8.4.2 Development Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Packaging & Labeling
8.5.1 Packaging & Labeling Market Trends Analysis (2020-2032)
8.5.2 Packaging & Labeling Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Market Approval & Post-marketing
8.6.1 Market Approval & Post-marketing Market Trends Analysis (2020-2032)
8.6.2 Market Approval & Post-marketing Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6.3 Early Phase/Preclinical
8.6.3.1 Early Phase/Preclinical Market Trends Analysis (2020-2032)
8.6.3.2 Early Phase/Preclinical Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6.4 Late Phase/Clinical
8.6.4.1 Late Phase/Clinical Market Trends Analysis (2020-2032)
8.6.4.2 Late Phase/Clinical Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Veterinary CRO and CDMO Market Segmentation, By Application
9.1 Chapter Overview
9.2 Medicines
9.2.1 Medicines Market Trends Analysis (2020-2032)
9.2.2 Medicines Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Medical Devices
9.3.1 Medical Devices Market Trends Analysis (2020-2032)
9.3.2 Medical Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3.3 Biologics
9.3.3.1 Biologics Market Trends Analysis (2020-2032)
9.3.3.2 Biologics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3.4 Pharmaceuticals
9.3.4.1 Pharmaceuticals Market Trends Analysis (2020-2032)
9.3.4.2 Pharmaceuticals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3.5 Others
9.3.5.1 Others Market Trends Analysis (2020-2032)
9.3.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.4 North America Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.2.5 North America Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.6.2 USA Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.2.6.3 USA Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.7.2 Canada Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.2.7.3 Canada Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.2.8.3 Mexico Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.6.3 Poland Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.7.3 Romania Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.5 Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.6.3 Germany Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.7.2 France Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.7.3 France Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.8.3 UK Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.9.3 Italy Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.10.3 Spain Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.13.3 Austria Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.5 Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.6.2 China Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.6.3 China Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.7.2 India Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.7.3 India Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.8.2 Japan Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.8.3 Japan Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.9.3 South Korea Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.10.3 Vietnam Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.11.3 Singapore Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.12.2 Australia Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.12.3 Australia Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.5 Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.6.3 UAE Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.4 Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.2.5 Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.4 Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.6.5 Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.6.6.3 Brazil Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.6.7.3 Argentina Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.6.8.3 Colombia Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Service Type (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Veterinary CRO and CDMO Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
11. Company Profiles
11.1 Charles River Laboratories
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Vetio
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 TriRx Pharmaceutical Services
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 LABIANA Group.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Aenova Group
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Oncovet Clinical Research (OCR)
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Argenta Group (KLIFOVET GmbH)
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Clinvet
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 VETSPIN
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Knoell
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Animal Type
Livestock Animals
Companion Animals
By Service Type
Discovery
Manufacturing
Development
Packaging & Labeling
Market Approval & Post-marketing
Early Phase/Preclinical
Late Phase/Clinical
By Application
Medicines
Biologics
Medical Devices
Pharmaceuticals
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Breastfeeding Accessories Market size was estimated at USD 2.55 billion in 2023 and is expected to reach USD 4.50 billion by 2032 with a growing CAGR of 6.5% during the forecast period of 2024-2032.
The Healthcare Contract Management Software Market Size was valued at USD 1.52 billion in 2023 and is expected to reach USD 9.1 billion by 2032 at a CAGR of 22.0%.
The Sexual Health Products Market Size was valued at USD 118.83 Billion in 2023, and is expected to reach USD 243.83 Billion by 2032, and grow at a CAGR of 8.71% over the forecast period 2024-2032.
Artificial Cervical Disc Market was valued at USD 2.43 Bn in 2023 and is expected to reach USD 8.56 Bn by 2032, growing at a CAGR of 15.10% from 2024 to 2032.
The Women’s Health Therapeutics Market Size was valued at USD 43.21 Bn in 2023 & will reach to USD 61.6 Bn by 2032 & grow at a CAGR of 4.05% by 2024-2032.
The Population Screening Market was valued at USD 26.65 billion in 2023 and is expected to reach USD 42.48 billion by 2032, growing at a CAGR of 5.34% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
